FIELD: chemistry.
SUBSTANCE: invention relates to a new compound represented by the formula (1)
wherein R1 represents a hydrogen atom, or its pharmacologically acceptable salt which has improved inhibitory effect towards CYP, as well invention relates to a pharmaceutical composition based on this compound having the action of the selective inhibitor of serotonin reuptake , an antidepressant, and an agent for the treatment or prevention of premature ejaculation.
EFFECT: document describes a paroxetine derivative.
18 cl, 1 dwg, 4 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
DERIVATIVES OF SITAXENTHAN | 2013 |
|
RU2622386C2 |
SUBSTITUTED GUANIDINE COMPOUNDS | 2017 |
|
RU2757279C2 |
DERIVATIVES OF OLIGOSACCHARIDES | 2004 |
|
RU2290408C2 |
NEW DERIVATIVE OF 3-AZABICYCLO[3.1.0]HEXANE AND USE THEREOF FOR MEDICAL PURPOSES | 2014 |
|
RU2701861C1 |
BENZIMIDAZOLE DERIVATIVES AS SELECTIVE ACID PUMP INHIBITORS | 2007 |
|
RU2412188C2 |
2,6-DIMETHYL-N-((PYRIDIN-4-YL)METHYL)IMIDAZO[1,2-B]PYRIDAZIN-8-AMINE AND 2,5-DIMETHYL-N-[(PYRIDIN-4-YL)METHYL DERIVATIVES ]PYRAZOLO[1,5-A]PYRIMIDIN-7-AMINE FOR THE TREATMENT OF VIRAL INFECTIONS | 2019 |
|
RU2798107C2 |
NOVEL ACID SECRETION INHIBITOR AND ITS USE | 2021 |
|
RU2815697C1 |
NEW GLUCITOL DERIVATIVE, PRODRUG AND SALT AND THERAPEUTIC AGENT CONTAINING THEM FOR DIABETES TREATMENT | 2005 |
|
RU2386631C2 |
NEPRILYSIN INHIBITORS | 2013 |
|
RU2663618C2 |
DERIVATIVES OF TETRAHYDROISOQUINOLINE, PHARMACEUTICAL COMPOSITION CONTAINING THEREOF, METHOD FOR INHIBITION OF SYNAPTIC UPTAKE OF DOPAMINE AND TREATMENT METHOD | 2000 |
|
RU2293728C2 |
Authors
Dates
2017-04-18—Published
2013-01-29—Filed